BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21126843)

  • 1. Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.
    Ma X; Oyamada S; Gao F; Wu T; Robich MP; Wu H; Wang X; Buchholz B; McCarthy S; Gu Z; Bianchi CF; Sellke FW; Laham R
    J Pharm Biomed Anal; 2011 Mar; 54(4):807-11. PubMed ID: 21126843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.
    Ma X; Oyamada S; Wu T; Robich MP; Wu H; Wang X; Buchholz B; McCarthy S; Bianchi CF; Sellke FW; Laham R
    J Biomed Mater Res A; 2011 Mar; 96(4):632-8. PubMed ID: 21268237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
    Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
    J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.
    Lee CH; Yu CY; Chang SH; Hung KC; Liu SJ; Wang CJ; Hsu MY; Hsieh IC; Chen WJ; Ko YS; Wen MS
    Int J Nanomedicine; 2014; 9():4117-33. PubMed ID: 25206303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
    Bedair TM; Kang SN; Joung YK; Han DK
    J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application.
    Lao LL; Venkatraman SS
    J Biomed Mater Res A; 2008 Oct; 87(1):1-7. PubMed ID: 18080309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.
    Wessely R; Kastrati A; Mehilli J; Dibra A; Pache J; Schömig A
    Eur Heart J; 2007 Nov; 28(22):2720-5. PubMed ID: 17921531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
    Choi J; Jang BN; Park BJ; Joung YK; Han DK
    Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.
    Carlyle WC; McClain JB; Tzafriri AR; Bailey L; Zani BG; Markham PM; Stanley JR; Edelman ER
    J Control Release; 2012 Sep; 162(3):561-7. PubMed ID: 22800575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
    Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
    Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent.
    Ren K; Zhang M; He J; Wu Y; Ni P
    ACS Appl Mater Interfaces; 2015 Jun; 7(21):11263-71. PubMed ID: 25955234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications.
    Zheng X; Wang Y; Lan Z; Lyu Y; Feng G; Zhang Y; Tagusari S; Kislauskis E; Robich MP; McCarthy S; Sellke FW; Laham R; Jiang X; Gu WW; Wu T
    J Biomed Nanotechnol; 2014 Jun; 10(6):900-10. PubMed ID: 24749387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.
    Chen S; Zhang J; Ye F; Zhu Z; Lin S; Tian N; Liu Z; Fang W; Chen Y; Sun X; Kwan TW
    Angiology; 2008; 59(4):475-83. PubMed ID: 18388098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
    Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
    Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.